제품 > 항체 > 단일클론항체(mAb)

SARS-CoV-2 Spike S1 mAb (A20022)

Publications (5) Datasheet

Tested applications:WBIHC-PIF/ICCIPChIPChIP-seqRIPFCFC(Intra)ELISAMeDIPNucleotide ArrayDBFACSCoIPCUT&TagmeRIPInhibitionReactivity:SARS-CoV-2

ABclonal:SARS-CoV-2 Spike S1 mAb
ABclonal:Western blot - SARS-CoV-2 Spike S1 mAb (A20022)

Western blot analysis of lysates from control 293T and SARS-CoV-2 Spike S1-293T trasfected cells, using SARS-CoV-2 Spike S1 mAb, BSA and glycerol free (A20022) at 1:10000 dilution.
Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) (AS014) at 1:10000 dilution.
Lysates/proteins: 25μg per lane.
Blocking buffer: 3% nonfat dry milk in TBST.
Detection: ECL Enhanced Kit (RM00021).
Exposure time: 180s.

Overview

Product nameSARS-CoV-2 Spike S1 mAb
Catalog No.A20022
Host speciesRabbit
Purification methodAffinity purification
IsotypeIgG
CloneNo.ARC2373
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The spike glycoprotein is found on the outside of the virus particle and gives coronavirus viruses their crown-like appearance. This glycoprotein mediates attachment of the virus particle and entry into the host cell. S protein is an important target for vaccine development, antibody therapies and diagnostic antigen-based tests.
ImmunogenRecombinant fusion protein of SARS-CoV-2 Spike S1.
SequenceEmail for sequence
Gene ID
Swiss Prot
Synonymsspike glycoprotein
Calculated MW
Observed MW110kDa
ReactivitySARS-CoV-2
Tested applicationsWBIHC-PIF/ICCIPChIPChIP-seqRIPFCFC(Intra)ELISAMeDIPNucleotide ArrayDBFACSCoIPCUT&TagmeRIPInhibition
Recommended dilution
  • WB 1:2000 - 1:10000
  • IF/ICC 1:200 - 1:800
  • FC 1:50 - 1:200
  • ELISA 1:1000 - 1:5000
Storage bufferStore at -20℃. Avoid freeze / thaw cycles.
Buffer: PBS with 0.02% sodium azide, 0.05% BSA, 50% glycerol, pH7.3.
Key applicationWestern blotting    Immunofluorescence    Flow Cytometry    
Positive samples293T cells transfected with SARS-CoV-2 Spike S1 protein
Cellular location
Customer validation

IF(Mus musculus, Homo sapiens)

IHC(Mus musculus)

WB(Mus musculus)

IHC(Mus musculus)

IF(Mus musculus)

Documents

Certificate of Compliance

To download a Certificate of Compliance, please enter your Lot number below:

Lot number

    ABclonal:Western blot - SARS-CoV-2 Spike S1 mAb (A20022)}

    Western blot - SARS-CoV-2 Spike S1 mAb (A20022)

    Western blot analysis of lysates from control 293T and SARS-CoV-2 Spike S1-293T trasfected cells, using SARS-CoV-2 Spike S1 mAb, BSA and glycerol free (A20022) at 1:10000 dilution.
    Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) (AS014) at 1:10000 dilution.
    Lysates/proteins: 25μg per lane.
    Blocking buffer: 3% nonfat dry milk in TBST.
    Detection: ECL Enhanced Kit (RM00021).
    Exposure time: 180s.

    * For research use only. Not for therapeutic or diagnostic purposes.

    Publishing research using A20022? Please let us know so that we can cite the reference in this datasheet.

    재조합 단백질 (35)

    항체 (10)

    ELISA 키트 (1)

    제품 (1)

    Secondary Antibodies (26)